Managed Care: Impact on the Industry

March 2010
Pharmaceutical Representative;Mar2010, Vol. 40 Issue 3, p24
The article presents Part 3 on the continuing education which discusses the effects of managed care on the pharmaceutical industry. It details the existing partnership arrangements, the risk-sharing incentives, and the contractual relationship between healthcare organizations and pharmaceutical companies. It reveals the new sales approaches and responsibilities of representatives in the managed care setting.


Related Articles

  • Legal affairs: Obama's agenda. Blesch, Gregg // Modern Healthcare;1/5/2009, Vol. 39 Issue 1, p28 

    The article discusses the legal issues in healthcare which will be addressed by U.S. President Barack Obama. Jeff Miles of Ober, Kaler, Grimes & Shriver suspects Obama's team will be more sympathetic to providers who say they are steamrolled by dominant managed-care payers. Obama has said...

  • The Ethicality of Capping Non-Economic Damages to Control Rising Healthcare Costs: Panacea or False and Misleading Practice? Milburn, Pamela; Odom, Lamar; Garcia, Anthony // Internet Journal of Healthcare Administration;2005, Vol. 3 Issue 1, p2 

    Since the mid-70's, the healthcare industry has been plagued with three primary concerns: quality, costs and access. Several incremental measures have been taken by Congress to address these issues, most notably the passage of the Health Maintenance Organizational Act of 1973, and the Balanced...

  • BIG Business and BIG TROUBLE. Gordon, Suzanne // Revolution: The Journal for RNs & Patient Advocacy;Jan/Feb2005, Vol. 6 Issue 1, p30 

    The article presents information on how medicine complicity with big business can endanger one's health. This year has been a bad one for the pharmaceutical industry. In recent months, newspaper stories exposed the dangers of drugs like Vioxx and Celebrex, prompting calls for more government...

  • Bridging the gap. Frederick, James // Drug Store News;8/24/98, Vol. 20 Issue 13, pCP23 

    Details the efforts of the United States chain pharmacy industry to craft a new role for community pharmacy as an important and valued partner in managed care and integrated patient health system. Collaborative pilot projects; Status of initiatives to win recognition and financial support from...

  • Does Managed Care Fuel Pharmaceutical Industry Growth? Murray, M.D.; deardorff, F.W. // PharmacoEconomics;1998, Vol. 14, p341 

    Managed-care organisations and the pharmaceutical industry have diametrically opposing objectives, though there is hidden common ground. On one hand, most managed-care organisations now want to reduce the cost of drugs or at least maintain drug costs as a hedge against inflation. On the other,...

  • Research & Markets: Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform and the Inter-linkages Bringing Them Together.  // Biomedical Market Newsletter;3/31/2011, p369 

    The article provides an overview of the top issues in the managed care market and examines how pharmaceutical industry affects the growth of managed care in the U.S. market. It reveals that both industries have invested in the research and development of disease management and medication...

  • Experts discuss HMO mandates for prescription drugs. Walker, Tracey // Managed Healthcare Executive;Feb2005, Vol. 15 Issue 2, p13 

    This article reports that the California Department of Managed Care issued rules requiring health maintenance organizations to provide broad coverage of medically necessary prescription drugs. According to the Ohio Association of Health Plans' Board Chairman Bill Epling, it is standard industry...

  • Core system architecture should support data leveraging. Moore, Ned // Managed Healthcare Executive;Feb2005, Vol. 15 Issue 2, p42 

    This article reports that the U.S. healthcare industry continues to evolve with innovations in all areas including care delivery, preventive care, patient education and benefits design. Much of a health plan's ability to keep pace with this acceleration depends upon the way it manages and...

  • PREFERENTIAL TREATMENT. Jeffords, Elizabeth // Medical Marketing & Media;Feb2012, Vol. 47 Issue 2, p47 

    The article reports on the advantages and drawbacks of the partnership between pharmaceutical companies and managed care firms to improve drug evidence and outcomes in the U.S. in 2012. It says that the team-up is beneficial to derive better outcomes in clinical trials, but it cannot address...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics